SCHEMBL2366895

SCHEMBL2366895

CON=C(C)Cc1ccc(Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LTA4H P09960 1/20 0.42
EPHX2 P34913 1/20 0.42
CNR2 P34972 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
S1PR5 Q9H228 1/20 0.38
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12082235 1.00 MAPT (0.49) MAPTALDH1A1KDM4EGAAKMT2A
SCHEMBL12082147 0.92 MAPT (0.48) MAPTALDH1A1KDM4EGAAKMT2A
SCHEMBL2366519 0.92 MAPT (0.48) MAPTALDH1A1KDM4EGAAKMT2A
SCHEMBL25890179 0.81 KDM4E (0.51) MAPTALDH1A1KDM4EGAAKMT2A
SCHEMBL2367221 0.76 POLB (0.56) MAPTALDH1A1KDM4EGAAKMT2A
SCHEMBL6446114 0.73 KMT2A (0.56) MAPTALDH1A1KMT2ALTA4HEPHX2
SCHEMBL10177918 0.73 MAPT (0.49) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL18840218 0.73 MAPT (0.49) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL19433075 0.73 MAPT (0.49) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL8067402 0.73 MEN1 (0.65) MAPTALDH1A1KDM4EGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364293-B1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2013-01-23 EP disclosed
US-8258169-B2 Pyrazole-4-N-alkoxycarboxamides as microbiocides SYNGENTA CROP PROTECTION, LLC (US) 2012-09-04 US disclosed
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2011-09-22 US disclosed
EP-2364293-A2 NOVEL MICROBIOCIDES Syngenta Participations AG (CH) 2011-09-14 EP disclosed
WO-2010063700-A2 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES CASP1, CASP14, CD14 MAPT 4788/4885ALDH1A1 390/4885KDM4E 1247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.